Categories AlphaGraphs, Earnings, LATEST, Technology
Netflix stock slides on disappointing subscriber growth in Q2
Shares of Netflix (NFLX) fell sharply on Monday after the streaming giant reported lower than expected subscriber growth for the second quarter. Meanwhile, revenues and earnings increased, helped mainly by the company’s aggressive expansion initiatives outside the US. The results came in above analysts’ forecast.
Adjusted net income jumped to $384 million or $0.85 per share from $66 million or $0.15 per share in the second quarter of 2017, and exceeded Wall Street Expectations.
Total revenues gained 40% annually to $3.91 billion, and total paid memberships advanced 26% to 124.35 million. International net subscriber additions rose 8% to 4.47 million, while domestic additions dropped 59% to 0.67 million.
Infographic: The rise of Netflix
Continuing the recent trend, Netflix reported negative cash flow of $559 million during the second quarter, which marked an improvement from the negative cash flow of $608 million recorded a year earlier. Cash flow has been under pressure from the company’s massive spending on new content.
After investing several billions of dollars in content acquisition, the company is enjoying a robust customer base that spreads across all regions. So far, the market has been bullish about the rapid subscription growth, which almost eclipsed the concerns about Netflix’s mounting debt.
Netflix continues to expand in the overseas market, building on original content and regional partnerships. In the last quarter, more than 90% of the subscriber additions came from the international market.
RELATED: Headwinds to Netflix’s growth
Earlier today, Buckingham Research Group downgraded Netflix’s stock to underperform from neutral in an unexpected move, cautioning investors that the company would face stiff competition in the overseas market.
RELATED: Netflix Q2 2018 earnings call transcript
Netflix shares hit an all-time high earlier this month after setting new records consistently over the years. The stock closed Monday’s regular session up 1.18%, but lost more than 13% during the extended session following the earnings report.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments
Comments are closed.